The placenta is the largest fetal organ, and toward the end of pregnancy the umbilical
circulation receives at least 40% of the biventricular cardiac output. It is not surprising …

Impaired placentation is an important contributing factor to intra-uterine growth restriction
and pre-eclampsia in fetuses with congenital heart defects (CHD). These pregnancy …

The placenta is a complex organ that influences prenatal growth and development, and
through fetal programming impacts postnatal health and well-being lifelong. Little …

The placenta is a vital organ for fetal growth and development during pregnancy. Congenital
heart disease (CHD) is a leading cause of morbidity and mortality in newborns. Despite the …

Preeclampsia is caused by placental impairment with increased expression of sFlt-1
(soluble fms-like tyrosine kinase 1) and decreased PlGF (placental growth factor); it has …

Objectives To determine the longitudinal behavior of fetal biometric measures and
cerebroplacental hemodynamics throughout gestation in fetuses with congenital heart …

Congenital heart defects (CHD) remain the most common class of birth defect worldwide,
affecting 1 in every 110 live births. A host of clinical and morphological indicators of …

Congenital heart disease (CHD) remains the most common birth defect in infants, and
critical CHD is associated with significant rates of morbidity and mortality. With the advent of …

Congenital heart disease (CHD) is an independent risk factor for brain injury, including
stroke, and poor neurodevelopmental outcomes, and placental abnormalities may represent …

OBJECTIVES Pregnancies with congenital heart disease in the foetus have an increased
prevalence of pre-eclampsia, small for gestational age and preterm birth, which are …